1-3 of 3
Martin Zimmermann
Close
Sort by
Journal Articles

The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL

Beat Bornhauser, Gunnar Cario, Anna Rinaldi, Thomas Risch, Virginia Rodriguez Martinez, Moritz Schütte, Hans-Jörg Warnatz, Nastassja Scheidegger, Paulina Mirkowska, Martina Temperli, Claudia Möller, Angela Schumich, Michael Dworzak, Andishe Attarbaschi, Monika Brüggemann, Mathias Ritgen, Ester Mejstrikova, Andreas Hofmann, Barbara Buldini, Pamela Scarparo, Giuseppe Basso, Oscar Maglia, Giuseppe Gaipa, Tessa Lara Skroblyn, Quy A. Ngo, Geertruij te Kronnie, Elena Vendramini, Renate Panzer-Grümayer, Malwine Jeanette Barz, Blerim Marovca, Mathias Hauri-Hohl, Felix Niggli, Cornelia Eckert, Martin Schrappe, Martin Stanulla, Martin Zimmermann, Bernd Wollscheid, Marie-Laure Yaspo, Jean-Pierre Bourquin
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4052–4064.
https://doi.org/10.1182/bloodadvances.2019000938
Published: 2020
Includes: Supplemental data
Journal Articles

Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

Clinical Trials & Observations
Franziska Schramm, Udo zur Stadt, Martin Zimmermann, Norbert Jorch, Arnulf Pekrun, Arndt Borkhardt, Thomas Imschweiler, Holger Christiansen, Jörg Faber, Irene Schmid, Tobias Feuchtinger, Gerhard Beron, Monique L. den Boer, Rob Pieters, Martin A. Horstmann, Gritta E. Janka-Schaub, Gabriele Escherich
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3688–3699.
https://doi.org/10.1182/bloodadvances.2019000576
Published: 2019
Includes: Supplemental data
Journal Articles

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

Clinical Trials & Observations
Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer, Valerie de Haas, Vincent H. J. van der Velden, Christine von Neuhoff, C. Michel Zwaan, Dirk Reinhardt, Jan-Henning Klusmann
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1532–1540.
https://doi.org/10.1182/bloodadvances.2018018945
Published: 2018
Includes: Supplemental data